Ketogenic diet, adenosine, and dopamine in addiction and psychiatry
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: March 10, 2025
Adhering
to
the
ketogenic
diet
can
reduce
or
stop
seizures,
even
when
other
treatments
fail,
via
mechanism(s)
distinct
from
available
therapies.
These
results
have
led
interest
in
for
treating
conditions
such
as
Alzheimer’s
disease,
depression
and
schizophrenia.
Evidence
points
neuromodulator
adenosine
a
key
mechanism
underlying
therapeutic
benefits
of
diet.
Adenosine
represents
unique
direct
link
among
cell
energy,
neuronal
activity,
gene
expression,
receptors
form
functional
heteromers
with
dopamine
receptors.
The
importance
dopaminergic
system
is
established
addiction,
are
challenges
modulating
directly.
A
mediator
that
could
antagonize
dopamine’s
effects
would
be
useful,
due
its
function
location.
Studies
report
improves
cognition,
sociability,
perseverative
behaviors,
might
improve
depression.
Many
translational
opportunities
based
on
diet/adenosine
come
fore,
including
autism
spectrum
disorder,
painful
conditions,
range
hyperdopaminergic
disorders.
Language: Английский
Ketogenic metabolic therapy for schizoaffective disorder: a retrospective case series of psychotic symptom remission and mood recovery
Nicole Laurent,
No information about this author
Erin L. Bellamy,
No information about this author
Katherine A. Tague
No information about this author
et al.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: Feb. 7, 2025
Schizoaffective
disorder
is
a
severe
psychiatric
condition
characterized
by
mood
disturbances
and
psychotic
symptoms.
Standard
treatments,
primarily
pharmacological,
often
fail
to
control
symptoms
fully
can
lead
significant
metabolic
side
effects.
Emerging
evidence
suggests
that
ketogenic
therapy
(KMT),
also
known
as
the
diet,
may
offer
powerful
alternative
conventional
treatments
for
components
resolve
in
patients
with
schizoaffective
disorder.
This
case
series
investigates
effects
of
KMT
on
two
individuals
diagnosed
who
pursued
this
due
ineffectiveness
treatments.
Both
presentations
followed
modified
diet
medical
oversight.
Symptom
changes
were
assessed
using
validated
tools,
including
Generalized
Anxiety
Disorder-7
(GAD-7),
Depression
Stress
Scales
(DASS-42),
PTSD
Checklist
DSM-5
(PCL-5),
Patient
Health
Questionnaire-9
(PHQ-9).
experienced
complete
cessation
improvements
mood.
Case
1,
17-year-old
female,
achieved
full
remission
suicidal
ideation,
hallucinations,
anxiety
within
6
weeks,
sustained
at
24-week
follow-up.
2,
32-year-old
chronic
months.
Patients
either
deprescription
or
process
time
demonstrates
disorder,
leading
functional
recovery
reported
quality
life
extend
beyond
symptom
standard
care
interventions.
Language: Английский
KETO-MOOD: Ketogenic Diet for Microbiome Optimization and Overcoming Depression: A Protocol for a Randomized Controlled Trial
Katarzyna Hongler,
No information about this author
A. Lounici,
No information about this author
Elmer R. Maurer
No information about this author
et al.
NeuroImmunoModulation,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 23
Published: Dec. 19, 2024
Major
Depressive
Disorder
(MDD)
significantly
impacts
millions
worldwide,
with
limited
success
in
achieving
remission
for
many
patients,
leading
to
high
disease
burden
and
increased
suicide
risk.
Psychotherapy
antidepressants,
although
effective,
do
not
provide
relief
all,
prompting
the
search
alternative
treatments.
Ketogenic
diets
have
demonstrated
positive
effects
on
brain
health.
Our
study
aims
investigate
efficacy
of
ketogenic
diet
alleviating
MDD
symptoms,
filling
a
critical
gap
psychiatric
treatment
options
offering
novel
dietary
approach
potential
mitigate
enhance
mental
well-being.
This
phase
randomized
controlled
trial
will
evaluate
ten-week
program
dietitian
counseling
meal
provision
versus
an
intervention
similar
dietetic
contact
promoting
healthy,
insulin-lowering,
non-ketogenic
diet.
The
primary
outcome
is
change
Patient
Health
Questionnaire
nine-item
depression
score.
Secondary
outcomes
include
cognitive
affective
mindfulness,
self-efficacy,
sleep,
function,
work
social
adjustment,
various
immunological,
metabolic,
microbiome
markers
at
weeks
6
10.
addresses
by
exploring
diet's
as
intervention.
Given
global
impact
limitations
current
therapies,
this
research
valuable
its
neuroprotective
metabolic
benefits.
It
advance
strategies
clarifying
underlying
mechanisms.
Language: Английский